Clinical Research and Clinical Trials in the Region of South-West Finland
By Mika Scheinin, Professor of Pharmacology, Institute of Biomedicine, University of Turku
The Turku region enterprises generate nearly half of the turnover of Finnish pharmaceutical industry. Special areas of application include hormonal diseases and cancer, inflammatory and infectious diseases, as well as central nervous system diseases. South-West Finland is a hotspot in biomedically oriented clinical research and in clinical drug development.
Its economic center, Turku, is a lively university town with good connections to Stockholm and Copenhagen, and via them, to the rest of the world. The University of Turku and Turku University Hospital are located on a single compact Turku Science Park campus and clinical and basic scientists move freely between these two organizations, creating a truly translational research environment.
Molecular biosciences and cardiovascular and metabolic research are special focus areas of the University. Imaging with positron emission tomography forms one of the internationally best known technology platforms in the region: Turku PET Centre is among the world leaders in the field in terms of research volume, quality and impact. Special emphasis has been placed on the creation of smooth and efficient procedures for collaboration with the pharmaceutical industry.
Get a presentation of clinical research and clinical trials in the region of South-Western Finland by following the link below.
28 June 2019
Deep Dive in Hannover
19 June 2019
WHINN 2019 (Odense)
14 June 2019
BioLab | PPNT Gdynia: More than 250 companies